Sekar Kathiresan, Chief Executive Officer at Verve Therapeutics, Inc. (VERV), bought 2,500 shares at $19.00 ($48K) on 2021-06-21, disclosed to the SEC on 2021-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| VERV | SELL | 2022-08-11 | $1.5M | — | Filing → |
| VERV | SELL | 2022-07-21 | $1.5M | — | Filing → |
| VERV | SELL | 2022-01-06 | $75K | — | Filing → |